Track topics on Twitter Track topics that are important to you
Phone: 31 413-251115
Fax: 31 413 266605
SanBio's US-based Phase 1/2a Clinical Trial of SB623 for the Treatment of Chronic Motor Deficit from Ischemic Stroke Was Addressed at an Event Held by California Institute for Regenerative Medicine (CIRM)
The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio, Inc.), a scientific leader in regenerative medicine for neurological disorders, hereby announces that the US-based...
SanBio Group has reported positive results from the Phase II STEMTRA trial after it met the primary endpoint. The STEMTRA...Read More... The post SanBio reports positive results from Phase II SB623 tr...
SanBio Co. Ltd. acquired Tulane University's patent portfolio surrounding cell therapies derived from mesenchymal stem cells (MSCs; multipotent cells capable of self-renewing and differentiating into ...
SanBio Co., Ltd. and US subsidiary SanBio, Inc. conducted the following personnel transfers, effective October 1, 2018. 1. Transfer DetailsAkihiro Tsujimura will become a...
The SanBio Group (SanBio Co., Ltd. and subsidiary SanBio Inc.; together, the “Company”) announces today that the Phase 2 STEMTRA trial using SB623 cells for the treatment of p...
The patent portfolio includes technology discovered by Aline Betancourt, a researcher at Tulane University. Betancourt’s technology optimizes anti-inflammatory and pro-inflammatory functions of MSCs...
SanBio: Supplementary Information to the Notice Regarding an Equity and Business Alliance Between Five Companies for Joint Research on the Appropriate Use, Adoption, and Stable Distribution of Regenerative Cell Medicine SB623
SanBio Co., Ltd. (representative: Keita Mori, headquarters: Chuo-ku, Tokyo; hereinafter SanBio) has agreed to enter into an equity and business alliance with CareNet, Inc. (repres...
SanBio is a regenerative medicine company with cell based products in various stages of research, development and clinical trials. Its proprietary cell based product, SB623, is be...
SanBio (TOKYO:4592) is a leading regenerative medical products company headquartered in Tokyo and Mountain View, California, with cell-based products in various stages of research...
Through regular contact with our customers in the Benelux and Germany, Sanbio has been able to offer a wide range of biotechnology and research products in the field of immunology, pathology, molecula...
We have published hundreds of SANBIO BV news stories on BioPortfolio along with dozens of SANBIO BV Clinical Trials and PubMed Articles about SANBIO BV for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SANBIO BV Companies in our database. You can also find out about relevant SANBIO BV Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...